A Parkinson-like neurologic deficit in primates is caused by a novel 4-substituted piperidine.
Brain Res
; 368(2): 239-46, 1986 Mar 19.
Article
in En
| MEDLINE
| ID: mdl-3697724
ABSTRACT
A neurologic deficit characterized by hypokinesia, postural flexion, and to a lesser extent, rigidity, tremor and myoclonus, has been observed in cynomolgus monkeys following administration of 1-methyl-4-(1-methylpyrrol-2-yl)-4-piperidinol (MMPP), a novel 4-substituted piperidine. The syndrome, similar to that described for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), developed within 3-7 days after oral or i.v. dosing, and was accompanied by lesions in the substantia nigra. The behavioral syndrome was seen to a lesser extent in dogs but not in rats. MMPP contains a hydroxyl group on the 4-position of the pyridine ring; the corresponding dehydration product was inactive.
Search on Google
Database:
MEDLINE
Main subject:
Parkinson Disease, Secondary
/
Peroxides
/
Phthalic Acids
/
Neurotoxins
Limits:
Animals
Language:
En
Year:
1986
Type:
Article